If you can now change your body, do you still have to love it? And can wanting to lose weight coexist with body acceptance?

Hosted by journalist Rose Stokes, who brings 30 years of lived experience with weight and obesity, and Dr Giles Yeo, a University of Cambridge scientist who has spent three decades studying why people are small, medium or large in our food environment, this podcast brings together lived experience and science without pretending to have all the answers.

In this episode, Rose and Giles explore what happened to body positivity and where it leaves us in the age of GLP-1 weight-loss medication. In a deeply personal conversation, Rose reflects on what the movement meant to her, the disappearance of bigger bodies from fashion and media, and why choosing to lose weight doesn’t mean abandoning everything she believes about acceptance.

We cover:

• Whether BMI is scientifically meaningless, or simply too limited to tell the whole story

• The “SkinnyTok” claim that hunger is a good thing

• Why fatphobia affects people across the weight spectrum

• The retreat from plus-size representation in fashion and advertising

• Why body acceptance and looking after your health don’t have to be at odds

• How celebrity culture and shifting beauty standards influence what we consider an “acceptable” body

• The difficulty of discussing extreme thinness without scrutinising someone else’s health

• Why blaming GLP-1 medication for the return of thinness culture misses the bigger picture

• Plus, Rose revisits her Herbalife experience, involving meal-replacement shakes, French food and an awkward encounter at customs

This episode contains a paid partnership with Wild Nutrition. Visit https://www.wildnutrition.com/amatteroffat to learn more about the offer mentioned in the show.

Transparency:

Professor Giles Yeo consults and speaks for Novo Nordisk, Eli Lilly and Amgen, and has received research grant funding from Novo Nordisk and Amgen. He is joining Amgen’s cardiometabolic scientific advisory board and also consults for Voy. Industry funds most obesity research, and these relationships are typical for senior researchers in the field.

Rose Stokes has taken GLP-1 medication and writes about weight and the pharmaceutical industry as a freelance journalist.

FOLLOW to stay up to date with A Matter of Fat.

FIND US

Instagram: https://www.instagram.com/amatteroffatpod/

Rose Stokes: https://www.instagram.com/rosestokes/

Giles Yeo: https://www.instagram.com/gilesyeo/

Questions, thoughts, constructive criticism or a story you want to share? Email us at amatteroffatpod@gmail.com

Hosted on Acast. See acast.com/privacy for more information.

Big Food helped create the obesity crisis. Should the same industry be allowed to profit from the solution?

A Matter of Fat is a podcast for anyone who has no idea what they think about weight, bodies and the rapidly changing conversation around them.

Hosted by journalist Rose Stokes, who brings 30 years of lived experience with weight and obesity, and Dr Giles Yeo, a University of Cambridge scientist who has spent three decades studying why people are small, medium or large in our food environment, this podcast brings together lived experience and science without pretending to have all the answers.

In episode five, Rose and Giles examine how ultra-processed food has reshaped our diets, appetites and health. They ask whether medication can repair the damage without letting policymakers and the food industry off the hook.

We cover:

•⁠ ⁠What “ultra-processed food” actually means and why the label can be misleading

•⁠ ⁠Whether UPFs are genuinely addictive

•⁠ ⁠Why processing can make calories easier for our bodies to absorb

•⁠ ⁠How food manufacturers engineer products that are cheap, convenient and difficult to resist

•⁠ ⁠Why genetics affect our appetites, food choices and responses to marketing

•⁠ ⁠The link between UPF consumption, poverty and obesity

•⁠ ⁠Why condemning supermarket bread can reveal more about privilege than health

•⁠ ⁠Whether unhealthy food should be taxed and healthier options subsidised

•⁠ ⁠How schools could help build a healthier food culture

•⁠ ⁠Whether GLP-1 medication is an antidote to our modern food environment

•⁠ ⁠Why weight-loss drugs must not become an excuse to avoid meaningful food reform

•⁠ ⁠Giles’s experience of seeing a close family member respond to GLP-1 medication

•⁠ ⁠Rose’s fears about her children inheriting her struggles with weight

•⁠ ⁠Plus, Rose revisits Slimming World and awards it zero doughnuts out of ten

This episode contains a paid partnership with Wild Nutrition. Visit https://www.wildnutrition.com/amatteroffat to learn more about the offer mentioned in the show.

Transparency:

Professor Giles Yeo consults and speaks for Novo Nordisk, Eli Lilly and Amgen, and has received research grant funding from Novo Nordisk and Amgen. He is joining Amgen’s cardiometabolic scientific advisory board and also consults for Voy. Industry funds most obesity research, and these relationships are typical for senior researchers in the field.

Rose Stokes has taken GLP-1 medication and writes about weight and the pharmaceutical industry as a freelance journalist.

SUBSCRIBE to stay up to date with A Matter of Fat.

FIND US

Instagram: https://www.instagram.com/amatteroffatpod/

Rose Stokes: https://www.instagram.com/rosestokes/

Giles Yeo: https://www.instagram.com/gilesyeo/

Questions, thoughts, constructive criticism or a story you want to share? Email us at amatteroffatpod@gmail.com

Hosted on Acast. See acast.com/privacy for more information.

Who gets to be healthy when nutritious food, time, exercise and weight-loss medication all cost money?

A Matter of Fat is a podcast for anyone who has no idea what they think about weight, bodies and the rapidly changing conversation around them.

Hosted by journalist Rose Stokes, who brings 30 years of lived experience with weight and obesity, and Dr Giles Yeo, a University of Cambridge scientist who has spent three decades studying why people are small, medium or large in our food environment, this podcast brings together lived experience and science without pretending to have all the answers.

In episode four, Rose and Giles ask whether good health is becoming something only wealthier people can afford.

We cover:

• Why eating healthily can take up a far greater percentage of a lower-income household’s budget

• The stark link between childhood obesity and socioeconomic inequality

• How time, stress, sleep, location and access to safe spaces shape our health

• The £100 to £350 monthly cost of accessing GLP-1 medication privately

• Why high prices are pushing some people towards unsafe workarounds

• How expiring patents could dramatically reduce the cost of these medications

• Why access to medication must also include proper mental health, nutritional and clinical support

• Why women make up the vast majority of current GLP-1 users

• What needs to change before these drugs become widely accessible

• Plus, Rose rates the years she spent exercising in almost every waking moment

Transparency:

Professor Giles Yeo consults and speaks for Novo Nordisk, Eli Lilly and Amgen, and has received research grant funding from Novo Nordisk and Amgen. He is joining Amgen's cardiometabolic scientific advisory board, and also consults for Voy. Industry funds most obesity research and these relationships are typical for senior researchers in the field.

Rose Stokes has taken GLP-1 medication and writes about weight and the pharmaceutical industry as a freelance journalist.

FOLLOW to stay up to date with A Matter of Fat.

FIND US

Instagram:

https://www.instagram.com/amatteroffatpod/

Rose Stokes:

https://www.instagram.com/rosestokes/

Giles Yeo:

https://www.instagram.com/gilesyeo/

Questions, thoughts, constructive criticism or a story you want to share? Email us at amatteroffatpod@gmail.com

Hosted on Acast. See acast.com/privacy for more information.